Dario C Altieri
Overview
Explore the profile of Dario C Altieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
173
Citations
12425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perego M, Yeon M, Agarwal E, Milcarek A, Bertolini I, Camisaschi C, et al.
J Clin Invest
. 2025 Jan;
135(2).
PMID: 39817447
No abstract available.
2.
Perego M, Yeon M, Agarwal E, Milcarek A, Bertolini I, Camisaschi C, et al.
J Clin Invest
. 2024 Aug;
134(22.
PMID: 39213189
The activation of innate immunity and associated interferon (IFN) signaling have been implicated in cancer, but the regulators are elusive and links to tumor suppression remain undetermined. Here, we found...
3.
Bialkowska K, El Khalki L, Rana P, Wang W, Lindner D, Parker Y, et al.
Sci Rep
. 2024 Aug;
14(1):19809.
PMID: 39191802
Kindlin-2 is a cytoskeletal adapter protein that is present in many different cell types. By virtue of its interaction with multiple binding partners, Kindlin-2 intercalates into numerous signaling pathways and...
4.
Verrillo C, Quaglia F, Shields C, Lin S, Kossenkov A, Tang H, et al.
J Extracell Vesicles
. 2024 Aug;
13(8):e12482.
PMID: 39105261
It is known that small extracellular vesicles (sEVs) are released from cancer cells and contribute to cancer progression via crosstalk with recipient cells. We have previously reported that sEVs expressing...
5.
Schaffer D, Li W, Elbasir A, Altieri D, Long Q, Auslander N
ISME Commun
. 2023 Dec;
3(1):128.
PMID: 38049632
Local microbiome shifts are implicated in the development and progression of gastrointestinal cancers, and in particular, esophageal carcinoma (ESCA), which is among the most aggressive malignancies. Short-read RNA sequencing (RNAseq)...
6.
Testa A, Quaglia F, Naranjo N, Verrillo C, Shields C, Lin S, et al.
Matrix Biol
. 2023 Nov;
124:49-62.
PMID: 37956856
Highly aggressive, metastatic, neuroendocrine prostate cancer, which typically develops from prostate cancer cells acquiring resistance to androgen deprivation therapy, is associated with limited treatment options and hence poor prognosis. We...
7.
Bertolini I, Perego M, Ghosh J, Kossenkov A, Altieri D
Oncogene
. 2023 Jun;
42(27):2195.
PMID: 37328686
No abstract available.
8.
Yeon M, Bertolini I, Agarwal E, Ghosh J, Tang H, Speicher D, et al.
J Biol Chem
. 2023 May;
299(6):104774.
PMID: 37142218
Mitochondria are signaling organelles implicated in cancer, but the mechanisms are elusive. Here, we show that Parkin, an E3 ubiquitination (Ub) ligase altered in Parkinson's disease, forms a complex with...
9.
Bertolini I, Perego M, Nefedova Y, Lin C, Milcarek A, Vogel P, et al.
J Clin Invest
. 2023 Mar;
133(8).
PMID: 36892943
The origin of breast cancer, whether primary or recurrent, is unknown. Here, we show that invasive breast cancer cells exposed to hypoxia release small extracellular vesicles (sEVs) that disrupt the...
10.
Bertolini I, Perego M, Ghosh J, Kossenkov A, Altieri D
Oncogene
. 2023 Jan;
42(9):708.
PMID: 36707623
No abstract available.